India registered about 12 lakh new cancer cases and 9.3 lakh deaths in 2019, becoming the second highest contributor to the disease burden in Asia for that year, according to a new study published......
India is in a much better position than other countries in the fight against COVID-19 as a result of "right decisions taken at the right time", Prime Minister Narendra Modi said on Monday,......
The number of cancer cases in the country is projected to go up from 14.6 lakh in 2022 to 15.7 lakh in 2025, according to the Indian Council of Medical Research-National Cancer Registry Programme,......
Codeine-based formulations are under the scanner for misuse as a narcotic product. IMAGE: In July, the government for the first time allowed a private company, Bajaj Healthcare, to process opium......
'Pollution acts as an endocrine disruptor.''When it acts as an endocrine disruptor it has an effect on the endocrine system of the human body and the effect on the pancreas is an important......
The University of Hyderabad, through one of its research initiatives, has discovered a natural product that prevents chemotherapy-induced toxic effects. The university plans to start human trials......
"If you are going to have a successful corporate program, it has to be directed from the top," says William Weldon, the CEO of Johnson & Johnson. He could be talking about cost-cutting initiatives......
'Leaders of the Indian community in Hong Kong had broached the idea of developing the Andaman and Nicobar islands for investment and setting up manufacturing units,' points out Rup Narayan Das.......
Ayushman Bharat aims at providing a cover of Rs 5 lakh per family annually and is aimed at benefitting more than 10 crore poor families across the country. Illustration: Uttam Ghosh/Rediff.com......
The budgetary allocation of Rs 6,400 crore was earmarked for the centre's flagship health insurance scheme Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (AB-PMJAY). The health outlay this......